References
- Suzuki R, Suzumiya J, Nakamura S, . Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004;18:763–770.
- Ito T, Makishima H, Nakazawa H, . Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation. Eur J Haematol 2008;81:107–111.
- Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 2007;139:532–544.
- Takahashi N, Miura I, Chubachi A, . A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-Cell lymphoma. Int J Hematol 2001;74:303–308.
- Ando M, Sugimoto K, Kitoh T, . Selective apoptosis of natural killer-cell tumours by L-asparaginase. Br J Haematol 2005;130: 860–868.
- Jaccard A, Gachard N, Marin B, . Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase II study. Blood 2011;117:1834–1839.
- Yong W, Zheng W, Zhu J, . L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type. Ann Hematol 2009;88:647–652.
- Yamaguchi M, Kwong YL, Kim WS, . Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011;29:4410–4416.
- Nagafuji K, Fujisaki T, Arima F, . L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol 2001;74:447–450.
- Matsumoto Y, Nomura K, Kanda-Akano Y, . Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma. Leuk Lymphoma 2003;44:879–882.
- Pieters R, Hunger SP, Boos J, . L-asparaginase treatment in acute lymphoblastic leukemia: focus on Erwinia asparaginase. Cancer 2011;117:238–249.
- Kwong YL. High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies. Bone Marrow Transplant 2009;44:709–714.
- Sato E, Ohga S, Kuroda H, . Allogenic hematopoietic stem cell transplantation for Epstein-Barr virus associated T/natural killer cell lymphoproliferative disease in Japan. Am J Hematol 2008;83:721–727.
- Ito T, Makishima H, Nakazawa H, . Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCT. Bone Marrow Transplant 2010;45:1–2.
- Suzuki R, Suzumiya J, Nakamura S, . Hematopoietic stem cell transplantation for natural killer-cell linage neoplasms. Bone Marrow Transplant 2006;37:425–431.